Skip to content
The Nexus
DossierENTITY

Xaira Therapeutics

Coverage of Xaira Therapeutics in the Nexus archive.

Earliest in view: Jun 22 · 06:53 UTCMost recent: Jun 22 · 06:53 UTC
Co-mentioned in this coverage
Recent coverage
  • BUSINESSJun 22 · 06:53 UTCSTAT NEWS
    STAT+: Sanofi names new R&D head as it tries to jumpstart pipeline

    Sanofi appointed Paulo Fontoura as global head of R&D to rejuvenate its pipeline under new CEO Belén Garijo. Fontoura, a neurologist with prior roles at Xaira Therapeutics and Roche, replaces Houman Ashrafian, who is leaving for an external opportunity.

Xaira Therapeutics · Dossier · The Nexus